Fuse Science, Inc. announced an update on the introduction of Macular's Health's new MacuDrop AREDS II formula containing Fuse Science(R) technology at the American Academy of Ophthalmology Meeting. Macular Health has partnered with Fuse Science(R) to develop new patent pending sublingual drop formulations to enhance treatment for Age-Related Macular Degeneration. AMD is a medical condition, which usually affects older adults and results in a loss of vision because of damage to the retina.

At the American Academy of Ophthalmology Meeting (AAO), November 16-19 2013, Macular Health showcased the MacuDrop AREDS II Formula.